No Data
No Data
Shanghai Kehua Bio-engineering (002022.SZ): The company currently does not have a store on e-commerce platforms.
On June 13, Gelonghui reported that Shanghai Kehua Bio-engineering (002022.SZ) stated on the interactive platform that the company adopts a sales model of "mainly distribution, supplemented by direct sales." The company implements different settlement methods for transportation costs based on customer type, purchase quantity, transportation time limits, transportation distances, etc. Currently, the company has not opened a store on any e-commerce platform.
Kehua Biotech: Report for the first quarter of 2025
Express News | Shanghai Kehua Bio-engineering: Net loss of 53.2598 million yuan in the first quarter of 2025.
Kehua Biotech: 2024 Annual Report
Kehua Biotech: 2024 Annual Report Summary
Express News | Shanghai Kehua Bio-engineering: The fully automated chemiluminescence immunoassay analyzer has obtained the medical instruments registration certificate.